TARGETED DRUG DELIVERY 
SYSTEM 
SHIPRA MALIK 
PHARMACEUTICS
CONTENTS 
• INTRODUCTION 
• NEED OF TDDS 
• ADVANTAGES & DISADVANTAGES 
• IDEAL TDDS 
• CARRIERS 
• STRATEGIES 
• SYSTEMS 
• MICROSPHERES: MAGNETIC MICROSPHERE 
• NANOPARTICLES
INTRODUCTION 
• Targeted drug delivery(Smart Drug Delivery) means selective and effective 
localization of drug into the target at therapeutic concentrations with 
limited access to non target sites . 
• The drug can be targeted to 
 an organ 
 particular tissue or cell 
 intracellular sites 
 virus or bacterial cells 
GOAL - prolong ,localize, target, and have a protected drug interaction with the 
diseased tissue.
NEED OF TARGETED DRUG DELIVERY
Advantages and Disadvantages 
ADVANTAGES 
• Reduction of drug side-effects 
• Reduced frequency of drug 
intake 
• Reduced dose of drug 
• Uniform blood level of drug 
• Maximizes the therapeutic 
index 
DISADVANTAGES 
• Rapid clearance of targeted 
systems 
• Immune reaction against 
carrier systems 
• Insufficient localization of 
targeted systems in tumor 
cells 
• Diffusion and redistribution of 
released drug 
• High cost
PROPERTIES OF IDEAL TDDS 
• It should be - 
o Non-toxic 
o Biocompatible 
o Biodegradable 
o Physicochemical stable both in-vivo & in-vitro 
• Controlled and predictable drug release 
• Minimal drug leakage 
• Carrier should be readily eliminated without causing any change in 
diseased state 
• Preparation should be easy, reproductive and cost effective 
• Drug release should not effect drug action
CARRIERS OR MARKERS 
Engineered vectors which retain drug inside or onto them to delivery it 
within or vicinity of target. 
PROPERTIES 
• Cross anatomical barriers; tumor vasculature 
• Linkage to be stable in biological fluids 
• Selectively and specifically recognize target cells
STRATEGIES OF DRUG TARGETING
Passive or Inverse 
PASSIVE 
• DDS targets the systemic 
circulation of body 
• Drug targeting occurs due to 
body’s natural response to the 
physicochemical properties of 
drug or carrier system 
• Example: uptake of some colloids 
by RES especially in liver or spleen 
=> ideal substrate for passive 
hepatic targeting of drug 
INVERSE 
• Uptake of the DDS like colloids by 
RES is avoided, hence called 
INVERSE TARGETING 
• Example: preinjection of large 
amount of blank colloidal carriers 
or macromolecules like dextran to 
saturate the RES system => drug 
targeting to NON-RES ORGANS
ACTIVE TARGETING 
• Carrier system is modified on its surface to deliver drug to a specific 
site 
• FIRST ORDER: distribution to the capillary bed of target site like 
lymphatic, cerebral ventricles etc. 
• SECOND ORDER: delivery to special cells like tumor or kupffer cells 
in liver. 
• THIRD ORDER: intracellular localization of dug carrier complex via 
endocytosis or ligand mediated entry where lysosomal degradation 
of carrier complex causes release of drug.
TARGETING STRATEGIES 
DUAL TARGETING 
• CARRIER MOLECULE also has their own therapeutic activity and thus increases 
therapeutic effect of drug 
• Net SYNERGISTIC EFFECT of drug conjugate 
DOUBLE TARGETING 
• TEMPORAL & SPATIAL methodologies are combined in a delivery system 
• SPATIAL PLACEMENT : targeting drugs to specific organs, tissues or 
subcellular compartments 
• TEMOPAL DELIVERY :controlling the rate of drug delivery
CARRIER SYSTEMS 
• Colloidal carriers 
• Cellular carriers 
: erythrocytes, platelets, antibodies 
• Supramolecular delivery system 
:micelles, lipoproteins(VLDL,LDL) 
• Polymer based system 
• Macromolecular carrier 
:MABS, polysaccharides
COLLOIDAL CARRIER SYSTEMS 
• Vesicular systems 
 Liposome 
 Virosome 
 Pharmacosome 
• Microparticulate systems 
 Nanoparticles 
 Microspheres
MICROSPHERES 
• Microspheres are small spherical particles, 
with diameters in the micrometer range 
(typically 1 μm to 1000 μm). 
• Also called as - 
– Microparticles 
– Microbeads
MATERIALS USED 
• NATURAL POLYMERS 
 Proteins: albumin, gelatin, collagen 
 Carbohydrates: starch, agarose 
 Chemically modified carbohydrates: poly(acryl) dextran, poly(acryl) 
starch 
• SYNTHETIC POLYMERS 
 Biodegradable: lactides & their gylcolides, polyanhydrides 
 Non-biodegradable: polymethyl methacrylate,acrolein
TYPES OF MICROSPHERE 
NATURE DESCRIPTION IMAGE APPLICATION 
BIO ADHESIVE •Intimate contact 
with absorption site 
•Prolonged 
residence time 
Nasal 
:gentamycin,insulin 
Ocular:methylpredni 
solone 
FLOATING 
(GRDDS) 
•Bulk density less 
than gastric fluid 
•2 types : hollow 
: microballon 
NSAIDS, 
antibiotics
TYPES OF MICROSPHERE 
NATURE DESCRIPTION IMAGE APPLICATION 
RADIO ACTIVE 
MICROSPHERES 
Radionuclide tightly 
bound to 
microbead 
Alpha:10cell layer 
Beta:Not more than 
12mm 
Gamma:several cm 
Diagnostic(gamma): 
spleen,liver imaging 
Therapeutic(alpha/ 
beta):radioemboliza 
tion therapy 
POLYMERIC 
MICROSPHERES 
•Biodegradable 
•Non-biodegradable 
•Swell in aqueous 
medium 
Vaccine :hepatitis 
Local:protein,horm 
ones
MAGNETIC MICROSPHERE 
• Supramolecular particles small enough to circulate through 
capillaries without producing embolic occlusion 
• But are to be captured in micro vessels 
• Dragged into the adjacent tissue by magnetic field of 0.5-0.8 Tesla 
• Magnetite(Fe3O4) : ferromagnetic material that is incorporated in 
microspheres to make them magnetically responsive
TARGETING OF MAGNETIC MICROBEAAD
REALEASE OF DRUG 
• Freely moves through the capillaries 
• Application of external magnetic field result in accumulation of drug 
at target site
APPLICATIONS OF MAGNETIC MICROBEADS 
• Localization of therapeutic agent 
• Bioengineering & biomedical trends like enzyme 
immobilization, protein purification, cell isolation 
• DNA analysis 
• Drug discovery 
• Molecular targeting
PREPARATION OF MICROSPHERES 
METHOD DESCRIPTION APPLICATION 
Emulsion solvent 
evaporation 
Drug+polymer sol=>to 
aqueous phase(PVP) = 
EMULSION(O/W) 
=>evaporate solvent = 
microsphere 
•Aceclofenac 
microspheres 
•Hollow microspheres 
Emulsion cross 
linking 
Drug=+Gelatin sol=>add drops 
to liquid 
paraffin=emulsion(W/O)=>MIC 
ROBEADS washed with 
isopropyl alcohol=>add to 
glutaraldehyde sol 
Gelatin A 
microspheres
PREPARATION OF MICROSPHERES 
METHOD DESCRIPTION APPLICATION 
Co-acervation Drug+Polymer sol=>phase 
separation -change in T,pH 
-salt or non solvent addition 
•Proteins 
•Steroids 
Emulsion-solvent 
diffusion 
Drug polymer 
mix+ethanol:dichloromethane 
(1:1)=>add dropwise to SLS 
sol=agitate at 40C => 
microbeads dried 
Microballons 
Ionic gelation Diclofenac sodium+ sodium 
alginate aq sol=>add to Ca2+ 
& chitosan sol in acetic acid = 
microsphere kept for 24 hrs 
for internal gellification 
Diclofenac sodium=> drug 
release at pH6.4-7.2
COACERVATION METHOD
NANOPARTICLES 
• 1-100 nanometer in size 
• Also called ULTRAFINE 
PARTICLES 
• NANOTECHNOLOGY defines particle as a small object that behaves 
as a whole unit with respect to its transport and properties
PROPERTIES 
• High surface area- volume ratio 
• Act as bridge between bulk materials and atomic/molecular 
structures 
• Size dependent properties are observed 
• Possess unexpected optical properties as they are small 
enough to confine their electrons and produce quantum 
effects
TYPES OF NANOPARTICLES 
NANO-CARRIER 
DESCRIPTION IMAGE APPLICATION 
NANO 
SHELLS 
Hollow silica 
spheres covered 
with gold 
Targeting tumor 
cells 
NANO 
WIRES 
Metallic:Au,Ni 
Semi 
conducting:Si, InP 
Insulating:SiO2 
Detect tumor in 
brain,treatment 
of Parkinson's
TYPES OF NANOPARTICLES 
QUANTAM 
DOTS 
Miniscule 
semiconductor 
particles 
Targeting 
cancerous cells 
GOLD 
NANOPARTICL 
ES 
Ultra sensitive 
detection system 
for DNA& 
proteins 
Genetic 
engineering 
DENDRIMERS Synthetic 
nanoparticle 
,510nm diameter 
Medical 
imaging, 
gene 
transfection
PREPARATION OF NANOPARTICLES 
• TOP DOWN 
Attrition : broad size distribution (10-1000 nm) 
: varied particle shape or geometry 
: impurities 
• BOTTOMS UP METHODS 
o Vapor phase fabrication: pyrolysis 
o Liquid phase fabrication: sol gel method
Fabrication
Marketed drugs 
BRAND GENERIC 
NAME 
INDICATION COMPANY 
Tricor® Fenofibrate Hypercholesterol 
emia 
Abbott 
Laboratories 
Avinza® Morphine 
sulphate 
Psycho stimulant Elan nano 
systems 
Rapamune® Rapamycin immunosuppresa 
nt 
Elan nano 
systems

Targeted drug delivery systems

  • 1.
    TARGETED DRUG DELIVERY SYSTEM SHIPRA MALIK PHARMACEUTICS
  • 2.
    CONTENTS • INTRODUCTION • NEED OF TDDS • ADVANTAGES & DISADVANTAGES • IDEAL TDDS • CARRIERS • STRATEGIES • SYSTEMS • MICROSPHERES: MAGNETIC MICROSPHERE • NANOPARTICLES
  • 3.
    INTRODUCTION • Targeteddrug delivery(Smart Drug Delivery) means selective and effective localization of drug into the target at therapeutic concentrations with limited access to non target sites . • The drug can be targeted to  an organ  particular tissue or cell  intracellular sites  virus or bacterial cells GOAL - prolong ,localize, target, and have a protected drug interaction with the diseased tissue.
  • 4.
    NEED OF TARGETEDDRUG DELIVERY
  • 5.
    Advantages and Disadvantages ADVANTAGES • Reduction of drug side-effects • Reduced frequency of drug intake • Reduced dose of drug • Uniform blood level of drug • Maximizes the therapeutic index DISADVANTAGES • Rapid clearance of targeted systems • Immune reaction against carrier systems • Insufficient localization of targeted systems in tumor cells • Diffusion and redistribution of released drug • High cost
  • 6.
    PROPERTIES OF IDEALTDDS • It should be - o Non-toxic o Biocompatible o Biodegradable o Physicochemical stable both in-vivo & in-vitro • Controlled and predictable drug release • Minimal drug leakage • Carrier should be readily eliminated without causing any change in diseased state • Preparation should be easy, reproductive and cost effective • Drug release should not effect drug action
  • 7.
    CARRIERS OR MARKERS Engineered vectors which retain drug inside or onto them to delivery it within or vicinity of target. PROPERTIES • Cross anatomical barriers; tumor vasculature • Linkage to be stable in biological fluids • Selectively and specifically recognize target cells
  • 8.
  • 9.
    Passive or Inverse PASSIVE • DDS targets the systemic circulation of body • Drug targeting occurs due to body’s natural response to the physicochemical properties of drug or carrier system • Example: uptake of some colloids by RES especially in liver or spleen => ideal substrate for passive hepatic targeting of drug INVERSE • Uptake of the DDS like colloids by RES is avoided, hence called INVERSE TARGETING • Example: preinjection of large amount of blank colloidal carriers or macromolecules like dextran to saturate the RES system => drug targeting to NON-RES ORGANS
  • 10.
    ACTIVE TARGETING •Carrier system is modified on its surface to deliver drug to a specific site • FIRST ORDER: distribution to the capillary bed of target site like lymphatic, cerebral ventricles etc. • SECOND ORDER: delivery to special cells like tumor or kupffer cells in liver. • THIRD ORDER: intracellular localization of dug carrier complex via endocytosis or ligand mediated entry where lysosomal degradation of carrier complex causes release of drug.
  • 11.
    TARGETING STRATEGIES DUALTARGETING • CARRIER MOLECULE also has their own therapeutic activity and thus increases therapeutic effect of drug • Net SYNERGISTIC EFFECT of drug conjugate DOUBLE TARGETING • TEMPORAL & SPATIAL methodologies are combined in a delivery system • SPATIAL PLACEMENT : targeting drugs to specific organs, tissues or subcellular compartments • TEMOPAL DELIVERY :controlling the rate of drug delivery
  • 12.
    CARRIER SYSTEMS •Colloidal carriers • Cellular carriers : erythrocytes, platelets, antibodies • Supramolecular delivery system :micelles, lipoproteins(VLDL,LDL) • Polymer based system • Macromolecular carrier :MABS, polysaccharides
  • 13.
    COLLOIDAL CARRIER SYSTEMS • Vesicular systems  Liposome  Virosome  Pharmacosome • Microparticulate systems  Nanoparticles  Microspheres
  • 14.
    MICROSPHERES • Microspheresare small spherical particles, with diameters in the micrometer range (typically 1 μm to 1000 μm). • Also called as - – Microparticles – Microbeads
  • 15.
    MATERIALS USED •NATURAL POLYMERS  Proteins: albumin, gelatin, collagen  Carbohydrates: starch, agarose  Chemically modified carbohydrates: poly(acryl) dextran, poly(acryl) starch • SYNTHETIC POLYMERS  Biodegradable: lactides & their gylcolides, polyanhydrides  Non-biodegradable: polymethyl methacrylate,acrolein
  • 16.
    TYPES OF MICROSPHERE NATURE DESCRIPTION IMAGE APPLICATION BIO ADHESIVE •Intimate contact with absorption site •Prolonged residence time Nasal :gentamycin,insulin Ocular:methylpredni solone FLOATING (GRDDS) •Bulk density less than gastric fluid •2 types : hollow : microballon NSAIDS, antibiotics
  • 17.
    TYPES OF MICROSPHERE NATURE DESCRIPTION IMAGE APPLICATION RADIO ACTIVE MICROSPHERES Radionuclide tightly bound to microbead Alpha:10cell layer Beta:Not more than 12mm Gamma:several cm Diagnostic(gamma): spleen,liver imaging Therapeutic(alpha/ beta):radioemboliza tion therapy POLYMERIC MICROSPHERES •Biodegradable •Non-biodegradable •Swell in aqueous medium Vaccine :hepatitis Local:protein,horm ones
  • 18.
    MAGNETIC MICROSPHERE •Supramolecular particles small enough to circulate through capillaries without producing embolic occlusion • But are to be captured in micro vessels • Dragged into the adjacent tissue by magnetic field of 0.5-0.8 Tesla • Magnetite(Fe3O4) : ferromagnetic material that is incorporated in microspheres to make them magnetically responsive
  • 19.
  • 20.
    REALEASE OF DRUG • Freely moves through the capillaries • Application of external magnetic field result in accumulation of drug at target site
  • 21.
    APPLICATIONS OF MAGNETICMICROBEADS • Localization of therapeutic agent • Bioengineering & biomedical trends like enzyme immobilization, protein purification, cell isolation • DNA analysis • Drug discovery • Molecular targeting
  • 22.
    PREPARATION OF MICROSPHERES METHOD DESCRIPTION APPLICATION Emulsion solvent evaporation Drug+polymer sol=>to aqueous phase(PVP) = EMULSION(O/W) =>evaporate solvent = microsphere •Aceclofenac microspheres •Hollow microspheres Emulsion cross linking Drug=+Gelatin sol=>add drops to liquid paraffin=emulsion(W/O)=>MIC ROBEADS washed with isopropyl alcohol=>add to glutaraldehyde sol Gelatin A microspheres
  • 23.
    PREPARATION OF MICROSPHERES METHOD DESCRIPTION APPLICATION Co-acervation Drug+Polymer sol=>phase separation -change in T,pH -salt or non solvent addition •Proteins •Steroids Emulsion-solvent diffusion Drug polymer mix+ethanol:dichloromethane (1:1)=>add dropwise to SLS sol=agitate at 40C => microbeads dried Microballons Ionic gelation Diclofenac sodium+ sodium alginate aq sol=>add to Ca2+ & chitosan sol in acetic acid = microsphere kept for 24 hrs for internal gellification Diclofenac sodium=> drug release at pH6.4-7.2
  • 24.
  • 25.
    NANOPARTICLES • 1-100nanometer in size • Also called ULTRAFINE PARTICLES • NANOTECHNOLOGY defines particle as a small object that behaves as a whole unit with respect to its transport and properties
  • 26.
    PROPERTIES • Highsurface area- volume ratio • Act as bridge between bulk materials and atomic/molecular structures • Size dependent properties are observed • Possess unexpected optical properties as they are small enough to confine their electrons and produce quantum effects
  • 27.
    TYPES OF NANOPARTICLES NANO-CARRIER DESCRIPTION IMAGE APPLICATION NANO SHELLS Hollow silica spheres covered with gold Targeting tumor cells NANO WIRES Metallic:Au,Ni Semi conducting:Si, InP Insulating:SiO2 Detect tumor in brain,treatment of Parkinson's
  • 28.
    TYPES OF NANOPARTICLES QUANTAM DOTS Miniscule semiconductor particles Targeting cancerous cells GOLD NANOPARTICL ES Ultra sensitive detection system for DNA& proteins Genetic engineering DENDRIMERS Synthetic nanoparticle ,510nm diameter Medical imaging, gene transfection
  • 29.
    PREPARATION OF NANOPARTICLES • TOP DOWN Attrition : broad size distribution (10-1000 nm) : varied particle shape or geometry : impurities • BOTTOMS UP METHODS o Vapor phase fabrication: pyrolysis o Liquid phase fabrication: sol gel method
  • 30.
  • 31.
    Marketed drugs BRANDGENERIC NAME INDICATION COMPANY Tricor® Fenofibrate Hypercholesterol emia Abbott Laboratories Avinza® Morphine sulphate Psycho stimulant Elan nano systems Rapamune® Rapamycin immunosuppresa nt Elan nano systems